Pharmaceuticals - Community Register


Community register of orphan medicinal products


Product information

Nitric oxide

EU orphan designation number: EU/3/13/1209   
Active ingredient: Nitric oxide
Indication: Treatment of cystic fibrosis
Sponsor: Novoteris
Diamantstraat 8, 2200 Herentals, België

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
20/12/2013 Orphan designation EMA/OD/095/13 (2013)9697 of 18/12/2013